Leishmaniasis is a neglected tropical disease and remains a global concern for healthcare.
It is caused by an opportunistic protozoan parasite belonging to the genus Leishmania and …

Leishmaniasis, a tropically neglected disease, is responsible for the high mortality and
morbidity ratio in poverty-stricken areas. Currently, no vaccine is available for the complete …

Background Visceral leishmaniasis (VL) caused by dimorphic Leishmania species is a
parasitic disease with high socioeconomic burden in endemic areas worldwide. Sustaining …

Leishmaniasis, a vector-borne parasitic protozoan disease, is among the most important
neglected tropical diseases. In the absence of vaccines, disease management is …

Kinetoplastids are the causative agents of leishmaniasis, human African trypanosomiasis,
and American trypanosomiasis. They are responsible for high mortality and morbidity in …

'One Health'summarises the idea that human health and animal health are interdependent
and bound to the health of ecosystems. The purpose of proteomics methodologies and …

Leishmaniases affect 12 million people worldwide. They are caused by Leishmania spp.,
protozoan parasites transmitted to mammals by female phlebotomine flies. During the life …

Leishmaniasis is one of the most impactful parasitic diseases worldwide, endangering the
lives of 1 billion people every year. There are 20 different species of Leishmania able to …

High-throughput proteomic technologies are widely used for understanding the disease
mechanism, drug-resistant mechanism, and to identify drug targets and markers for …

Visceral leishmaniasis (VL), mainly caused by the Leishmania donovani parasitic infection,
constitutes a potentially fatal disease, for which treatment is primarily dependent on …